Abstract
Tissue-type plasminogen activator (t-PA) has a short half-life in the circulation because the enzyme is rapidly cleared by the liver. This short review summarizes recent literature concerning mechanisms of uptake and degradation of t-PA in the liver. In vivo studies in rats show that degradation takes place via a lysosomal pathway. Saturation of the uptake system at high t-PA concentrations suggests a receptor-mediated mechanism. Competition experiments with various glycoproteins indicate that the asialoglycoprotein receptor is not involved, but they point to a role for the mannose receptor, which recognizes t-PA via its high mannose-type oligosaccharide on the first kringle domain. Both in vivo and in vitro studies with isolated liver cells demonstrate that parenchymal cells, as well as liver endothelial cells, are involved in the clearance of t-PA. Parenchymal cells, as the hepatoma cell line Hep G2, endocytose t-PA via a still unknown, possibly t-PA specific receptor, while liver endothelial cells catabolize t-PA via the mannose receptor.
References
Feb 1, 1989·Thrombosis Research·P J BugelskiD G Morgan
Oct 1, 1986·The American Journal of Cardiology·H D GarabedianD Collen
Sep 15, 1986·The Biochemical Journal·D C Rijken, J J Emeis
Dec 1, 1987·The Journal of Clinical Investigation·K A HajjarR L Nachman
Dec 30, 1987·European Journal of Biochemistry·G PohlM Einarsson
Apr 1, 1988·Circulation·C L LucoreB E Sobel
Jul 1, 1988·Thrombosis Research·D P Beebe, D L Aronson
Aug 15, 1985·Thrombosis Research·S NilssonC Mattsson
Sep 1, 1984·Proceedings of the National Academy of Sciences of the United States of America·T NyB Lund
Jan 1, 1980·Cell·P StahlY C Lee
Jun 18, 1981·Nature·O MatsuoD Collen
Citations
Jul 1, 1992·Naunyn-Schmiedeberg's Archives of Pharmacology·U MartinK Strein
Dec 1, 2001·Thrombosis Research·T NoguchiT Ariga
Mar 6, 2003·Thrombosis Research·Marcia R NagaokaDurval R Borges
Dec 1, 1991·Bio/technology·C F GoocheeJ R Rasmussen
Aug 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·K OrthJ Herz
Aug 17, 2005·Journal of Virology·Sophie Alcon-LePoderMarie Flamand
Oct 20, 2005·The British Journal of Ophthalmology·R C Tripathi, B J Tripathi
Oct 1, 1991·The Journal of Clinical Investigation·J D VassalliD Belin
Feb 20, 2010·PLoS Pathogens·Aaron K Neumann, Ken Jacobson
Aug 21, 2001·The Journal of Investigative Dermatology·G SzolnokyL Kemény
Aug 22, 2012·Journal of Thrombosis and Haemostasis : JTH·D C RijkenF W G Leebeek
Jul 1, 1993·Thrombosis Research·T NyM Ohlsson
May 1, 1991·Thrombosis Research·U MartinK Strein
Mar 8, 2006·Seminars in Fetal & Neonatal Medicine·Courtney Thornburg, Steven Pipe
Feb 23, 2017·Scientific Reports·Mozhgan RaiganiFereidoun Mahboudi
Sep 1, 1992·Thrombosis Research·H StockingerS Fischer
Feb 7, 1994·FEBS Letters·P A AndreasenJ Gliemann
Jul 1, 1992·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·M OtterD C Rijken
May 8, 2009·Biological & Pharmaceutical Bulletin·Nana KawasakiTeruhide Yamaguchi
Jan 14, 1991·FEBS Letters·L R WingN A Booth
Sep 29, 2020·Frontiers in Physiology·Alex L WilkinsonShishir Shetty
Nov 5, 2019·Molecular Biology Reports·Reza NedaeiniaMaryam Ranjbar
May 1, 1996·Trends in Biotechnology·M J Cho, R Juliano
Apr 5, 1995·Biochimica Et Biophysica Acta·P M RuddR A Dwek
Sep 24, 2021·Seminars in Liver Disease·Daniel A PattenShishir Shetty